Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 289 Records) |
Query Trace: Sarcoma and Kras[original query] |
---|
Molecular Characteristics and the Effect of KRAS Mutation on the Prognosis of Immunotherapy in Non-Small Cell Lung Cancer in Xinjiang, China. OncoTargets and therapy 2022 9 15 1021-1032. Gu Guomin, Yu Bo, Wan Hua, Lu Suqiong, Zhu Xiaodan, Zhao Yan, Fuxi Yujing, Liu Chunli |
Correlations of switch/sucrose nonfermentable complex mutations with clinical outcomes in advanced non-small cell lung cancer. Thoracic cancer 2022 Sep . Chang Geyun, Li Weihua, Bai Hua, Duan Jianchun, Wang Zhijie, Du Xinyang, Yu Ruofei, Wang Yaxi, Wang Minghao, Zhu Yixiang, Zhang Xue, Li Li, Wan Rui, Wang J |
A retrospective study for prognostic significance of type II diabetes mellitus and hemoglobin A1c levels in non-small cell lung cancer patients treated with pembrolizumab. Translational lung cancer research 2022 9 11 (8): 1619-1630. Shen Yinchen, Li Jiaqi, Qiang Huiping, Lei Yuqiong, Chang Qing, Zhong Runbo, Stella Giulia Maria, Gelsomino Francesco, Kim Yeon Wook, Abed Afaf, Qian Jialin, Chu Tianqi |
Prognosis and oncogenomic profiling of patients with tropomyosin receptor kinase fusion cancer in the 100,000 genomes project. Cancer treatment and research communications 2022 Aug 33 100623. Bridgewater John, Jiao Xiaolong, Parimi Mounika, Flach Clare, Stratford Jeran, Kamburov Atanas, Schmitz Arndt A, Zong Jihong, Reeves John A, Keating Karen, Bruno Amanda, Fellous Marc, Pereira Mariana Buongermino, Bazhenova Lyudmi |
Therapeutic Outcomes and Clinical Features of Advanced Non-Small Cell Lung Cancer Carrying KRAS Mutations: A Multicenter Real-life Retrospective Study. Clinical lung cancer 2022 Jul . Mazzaschi Giulia, Perrone Fabiana, Minari Roberta, Verzè Michela, Azzoni Cinzia, Bottarelli Lorena, Pluchino Monica, Armillotta Maria Pia, Ubaldi Annalisa, Altimari Annalisa, Gruppioni Elisa, Sperandi Francesca, Andrini Elisa, Guaitoli Giorgia, Bettelli Stefania, Longo Lucia, Bertolini Federica, Barbieri Fausto, Pagano Maria, Bonelli Candida, Tagliavini Elena, Nicoli Davide, Ubiali Alessandro, Zangrandi Adriano, Trubini Serena, Proietto Manuela, Gnetti Letizia, Tiseo Marcello, |
Mutations matter: An observational study of the prognostic and predictive value of KRAS mutations in metastatic colorectal cancer. Frontiers in oncology 2022 12 12 1055019. Lavacchi Daniele, Fancelli Sara, Roviello Giandomenico, Castiglione Francesca, Caliman Enrico, Rossi Gemma, Venturini Jacopo, Pellegrini Elisa, Brugia Marco, Vannini Agnese, Bartoli Caterina, Cianchi Fabio, Pillozzi Serena, Antonuzzo Loren |
High frequency of KRAS and EGFR mutation profiles in BRAF-negative thyroid carcinomas in Indonesia. BMC research notes 2022 12 15 (1): 369. Heriyanto Didik Setyo, Laiman Vincent, Limantara Nikko Vanda, Anantawikrama Widyan Putra, Yuliani Fara Silvia, Cempaka Rita, Anwar Sumadi Lukm |
Clinical predictors of treatment efficacy and a prognostic nomogram in patients with lung adenocarcinoma receiving immune checkpoint inhibitors: a retrospective study. Journal of thoracic disease 2022 11 14 (10): 4096-4112. Hu Fang, Peng Jin, Niu Yanjie, Mao Xiaowei, Zhao Yizhuo, Jiang Liy |
Mutation Profile via Next-Generation Sequencing in Patients with Colorectal Adenocarcinoma and Its Clinicopathological Correlation. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 2023 9 . Sibel Osman, Nesibe Kahraman Çetin, ?brahim Halil Erdo?du, ?brahim Meteo? |
Effect of the MiR-99b and MiR-135b on peritoneal carcinomatosis and liver metastasis in colorectal cancer. Clinics (Sao Paulo, Brazil) 2023 8 78 100271. Mehmet Aziret, Gamze Eskiler, Gözde Çak?rsoy Çakar, Metin Ercan, Cemil Bilir, Erdal Polat, Havva Belma Koçer, Ebru Kayra Y?ld?r?m, Mustafa Duman, Asuman Deveci Özk |
Impact of KRAS subtype and concurrent pathogenic mutations on advanced non-small cell lung cancer outcomes. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2023 7 . Enrique Caballé-Perez, Norma Hernández-Pedro, Maritza Ramos-Ramírez, Pedro Barrios-Bernal, Eunice Romero-Núñez, José Lucio-Lozada, Santiago Ávila-Ríos, Gustavo Reyes-Terán, Andrés F Cardona, Oscar Arrie |
KRAS mutations and their associations with clinicopathological features and survival in Vietnamese non?polyp colon cancer patients. Molecular and clinical oncology 2023 7 19 (2): 63. Hoang Minh Cuong, Vu Hong Thang, Bui-Thi Thu Huong, Nguyen Thuan Loi, Nguyen Minh D |
Prevalence of KRAS G12C Mutation and Co-mutations and Associated Clinical Outcomes in Patients With Colorectal Cancer: A Systematic Literature Review. The oncologist 2023 7 . John H Strickler, Takayuki Yoshino, Kendall Stevinson, Christian Stefan Eichinger, Christina Giannopoulou, Marko Rehn, Dominik Paul Mode |
A multi-institutional observational study evaluating the incidence and the clinicopathological characteristics of NeoRAS wild-type metastatic colorectal cancer. Translational oncology 2023 6 35 101718. Hiroki Osumi, Atsuo Takashima, Akira Ooki, Yuri Yoshinari, Takeru Wakatsuki, Hidekazu Hirano, Izuma Nakayama, Natsuko Okita, Ryoichi Sawada, Kota Ouchi, Koshiro Fukuda, Shota Fukuoka, Mariko Ogura, Daisuke Takahari, Keisho Chin, Hirokazu Shoji, Ken Kato, Naoki Ishizuka, Narikazu Boku, Kensei Yamaguchi, Eiji Shinoza |
TERT Mutations in Non-Small Cell Lung Cancer: Clinicopathologic Features and Prognostic Implications. Clinical Medicine Insights. Oncology 2023 6 17 11795549221140781. Liu Yang, Meng Wang, Na Li, Lu-Da Yan, Wen Zhou, Zhi-Qiong Yu, Xiao-Chun Peng, Jun Cai, Yong-Hua Ya |
Intracranial Efficacy of Adagrasib in Patients From the KRYSTAL-1 Trial With KRAS-Mutated Non-Small-Cell Lung Cancer Who Have Untreated CNS Metastases. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2023 6 JCO2300046. Marcelo V Negrao, Alexander I Spira, Rebecca S Heist, Pasi A Jänne, Jose M Pacheco, Jared Weiss, Shirish M Gadgeel, Karen Velastegui, Wenjing Yang, Hirak Der-Torossian, James G Christensen, Joshua K Saba |
Clinicopathological Characteristics and Mutational Landscape of APC, HOXB13, and KRAS among Rwandan Patients with Colorectal Cancer. Current issues in molecular biology 2023 5 45 (5): 4359-4374. Felix Manirakiza, Eric Rutaganda, Hidetaka Yamada, Yuji Iwashita, Belson Rugwizangoga, Benoit Seminega, Vincent Dusabejambo, Gervais Ntakirutimana, Deogratias Ruhangaza, Annette Uwineza, Kazuya Shinmura, Haruhiko Sugimu |
Identification of KRAS mutation and HER2 expression in Indonesian colorectal cancer population: a cross-sectional study. Annals of medicine and surgery (2012) 2023 5 85 (5): 1761-1768. Reno Rudiman, Alma Wijaya, Yunia Sribudiani, Hardi Siswo Soedjana, Hesti Lina Wiraswati, Etis Pramaswati, Prapanca Nugraha, Kiki Lukm |
The Unique Genetic Mutation Characteristics Based on Large Panel Next-Generation Sequencing (NGS) Detection in Multiple Primary Lung Cancers (MPLC) Patients. Discovery medicine 2023 5 35 (175): 131-143. Zhu Liang, Guoxiong Zeng, Wang Wan, Biao Deng, Chunyuan Chen, Fasheng Li, Guanzhou Lin, Yuying Lin, Haitao Lin, Guixi Mo, Huilai Mi |
RANKL acts an unfavorable prognostic biomarker and potential target in advanced KRAS-mutated lung adenocarcinoma. Thoracic cancer 2023 4 . Li Hong-Shuai, Liu Cheng-Ming, Wang Y |
Biomarker expression and survival in patients with non-small cell lung cancer receiving adjuvant chemotherapy in Denmark. PloS one 2023 4 18 (4): e0284037. Dalvi Tapashi, Nørgaard Mette, Fryzek Jon P, Movva Naimisha, Pedersen Lars, Pham Hansen Hanh, Walker Jill, Midha Anita, Shire Norah, Boothman Anne-Marie, Rigas James, Mellemgaard Anders, Rasmussen Torben R, Hamilton-Dutoit Stephen, Cronin-Fenton Deird |
Efficacy of immunotherapy as second-line or later-line therapy and prognostic significance of KRAS and/or TP53 mutations in advanced non-small cell lung cancer patients. European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2023 4 . Liu Jingya, Gao Jiani |
Relationship between PET/CT images and KRAS gene mutations in colorectal cancer in Vietnamese patients. European review for medical and pharmacological sciences 2023 3 27 (4): 1480-1486. Dan N V, Phuong P C, Thai P V, Nguyen N H, Loi N T, Cong B |
USH2A mutation and specific driver mutation subtypes are associated with clinical efficacy of immune checkpoint inhibitors in lung cancer. Journal of Zhejiang University. Science. B 2023 2 24 (2): 143-156. Yang Dexin, Feng Yuqin, Lu Haohua, Chen Kelie, Xu Jinming, Li Peiwei, Wang Tianru, Xia Dajing, Wu Yih |
Identification of methyltransferase modification genes associated with prognosis and immune features of pancreatic adenocarcinoma. Molecular and cellular probes 2023 2 67 101897. Wang Wentao, Zhang Dongyuan, Chang Donglei, Li Yupeng, Ren L |
The impact of RAS mutation on the treatment strategy of colorectal cancer. Medicine and pharmacy reports 2023 2 96 (1): 5-15. Pirvu Edvina Elena, Severin Emilia, Ni?? Irina, Toma ?tefania Andre |
Blood Liquid Biopsy in an Advanced Medullary Thyroid Carcinoma: A Case Study with Rearranged during Transfection Heterogeneity. Pathobiology : journal of immunopathology, molecular and cellular biology 2023 2 1-7. Gumà Josep, Peña Karla Beatríz, Riu Francesc, Lucia-Gozálvez Clara, Vidaller Ana, Maldonado Vanesa, Parada Dav |
NLRP3 inflammasome activation and symptom burden in KRAS-mutated CMML patients is reverted by IL-1 blocking therapy. Cell reports. Medicine 2023 12 4 (12): 101329. Laura Hurtado-Navarro, Ernesto José Cuenca-Zamora, Lurdes Zamora, Beatriz Bellosillo, Esperanza Such, Eva Soler-Espejo, Helios Martínez-Banaclocha, Jesús M Hernández-Rivas, Javier Marco-Ayala, Laura Martínez-Alarcón, Lola Linares-Latorre, Sara García-Ávila, Paula Amat-Martínez, Teresa González, Montserrat Arnan, Helena Pomares-Marín, Gonzalo Carreño-Tarragona, Tzu Hua Chen-Liang, María T Herranz, Carlos García-Palenciano, María Luz Morales, Andrés Jerez, María L Lozano, Raúl Teruel-Montoya, Pablo Pelegrín, Francisca Ferrer-Mar |
Estrogen/Progesterone Receptor Loss, CTNNB1 and KRAS Mutations Are Associated With Local Recurrence or Distant Metastasis in Low-Grade Endometrial Endometrioid Carcinoma. Applied immunohistochemistry & molecular morphology : AIMM 2023 1 31 (3): 181-188. Chibbar Rajni, Foerstner Sabrina, Suresh Janarathnee, Chibbar Richa, Piche Alexandre, Kundapur Deeksha, Kanthan Rani, Kundapur Vijayanand, Lee Cheng Han, Agrawal Anita, Lai Raymo |
Demographics and additional haematologic cancers of patients with histiocytic/dendritic cell neoplasms. Histopathology 2024 1 . Paul G Kemps, Lennart Kester, Marijn A Scheijde-Vermeulen, Carel J M van Noesel, Robert M Verdijk, Arjan Diepstra, Ariënne M W van Marion, Natasja Dors, Cor van den Bos, Annette H Bruggink, Pancras C W Hogendoorn, Astrid G S van Halter |
- Page last reviewed:Feb 1, 2024
- Page last updated:Mar 25, 2024
- Content source: